Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Vaccine effectiveness against COVID-19 breakthrough infections in patients with cancer (UKCCEP): a population-based test-negative case-control study.

Autor: Lee LYW; Department of Oncology, University of Oxford, Oxford, UK; Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, UK. Electronic address: lennard.lee@oncology.ox.ac.uk., Starkey T; Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, UK., Ionescu MC; UK Health Security Agency, London, UK., Little M; Department of Oncology, Oxford University Hospitals NHS Foundation Trust, Oxford, UK., Tilby M; Department of Oncology, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK., Tripathy AR; Department of Oncology, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK., Mckenzie HS; Oncology Department, University Hospital Southampton NHS Foundation Trust, Southampton, UK., Al-Hajji Y; Birmingham Medical School, University of Birmingham, Birmingham, UK., Barnard M; UK Health Security Agency, London, UK., Benny L; UK Health Security Agency, London, UK., Burnett A; NHS England, London, UK; NHS Improvement, London, UK., Cattell EL; Department of Cancer, Taunton and Somerset NHS Foundation Trust, Taunton, UK., Charman J; National Disease Registration Service, NHS Digital, London, UK., Clark JJ; Department of Surgery and Cancer, Imperial College London, London, UK., Khan S; Leicester Cancer Research Centre, University of Leicester, Leicester, UK., Ghafoor Q; Department of Oncology, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK., Illsley G; UK Health Security Agency, London, UK., Harper-Wynne C; Kent Oncology Centre, University of Kent and Kent and Medway Medical School, Maidstone, UK., Hattersley RJ; Department of Oncology, Torbay Hospital NHS Foundation Trust, Torquay, UK., Lee AJX; UCL Cancer Institute, University College London Hospitals NHS Trust and University College London, London, UK., Leonard PC; Cancer Services, Barking, Havering and Redbridge University Hospitals NHS Trust, Romford, UK., Liu JKH; Leeds Institute of Medical Research at St James's, University of Leeds, Leeds, UK., Pang M; Department of Health and Social Care, London, UK., Pascoe JS; Department of Oncology, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK., Platt JR; Leeds Institute of Medical Research at St James's, University of Leeds, Leeds, UK., Potter VA; Department of Oncology, University Hospital Coventry and Warwickshire, Coventry, UK., Randle A; Royal College of Physicians, London, UK., Rigg AS; Department of Oncology, Guy's and St Thomas' NHS Foundation Trust, London, UK., Robinson TM; Population Health Sciences, University of Bristol, Bristol, UK., Roques TW; Cancer Services, Norfolk and Norwich University Hospitals NHS Foundation Trust, Norwich, UK., Roux RL; Department of Oncology, Oxford University Hospitals NHS Foundation Trust, Oxford, UK., Rozmanowski S; Department of Health and Social Care, London, UK., Tuthill MH; Department of Oncology, Oxford University Hospitals NHS Foundation Trust, Oxford, UK., Watts I; Department of Academic Oncology, Royal Free Hospital, London, UK., Williams S; Department of Oncology, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK., Iveson T; Cancer Sciences, University of Southampton, Southampton, UK., Lee SM; UCL Cancer Institute, University College London Hospitals NHS Trust and University College London, London, UK; CRUK Lung Cancer Centre of Excellence, University College London Hospitals NHS Trust and University College London, London, UK., Middleton G; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK; Department of Oncology, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK., Middleton M; Department of Oncology, University of Oxford, Oxford, UK., Protheroe A; Department of Oncology, Oxford University Hospitals NHS Foundation Trust, Oxford, UK., Fittall MW; Cancer Services, The Royal Marsden NHS Foundation Trust, London, UK., Fowler T; UK Health Security Agency, London, UK., Johnson P; NHS England, London, UK; Cancer Sciences, University of Southampton, Southampton, UK.

Publikováno v: The Lancet. Oncology [Lancet Oncol] 2022 Jun; Vol. 23 (6), pp. 748-757. Date of Electronic Publication: 2022 May 23.

Lessons for tuberculosis vaccines from respiratory virus infection.

Autor: Beverley PC; The University of Oxford, Nuffield Department of Clinical Medicine, Edward Jenner Institute for Vaccine Research, Compton, Berkshire, RG20 7NN, UK. peter.beverley@jenner.ac.uk, Tchilian EZ

Publikováno v: Expert review of vaccines [Expert Rev Vaccines] 2008 Oct; Vol. 7 (8), pp. 1165-72.